Author

M. Weirick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:benchmark study· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

S. Gouma· 2 shared D. Weissman· 1 shared H. Muramatsu· 1 shared K. Parkhouse· 1 shared N. Pardi· 1 shared S. E. Hensley· 1 shared S. H. Y. Fan· 1 shared S. Hensley· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

S. Gouma

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nucleoside-modified mRNA-based influenza vaccines circumvent problems associated with H3N2 vaccine strain egg-adaptation

S. Gouma, K. Parkhouse, M. Weirick, H. Muramatsu, N. Pardi, S. H. Y. Fan, D. Weissman, S. E. Hensley

This study compares H3N2 vaccine efficacy between mRNA-LNP and egg-based vaccines, finding that mRNA-LNP vaccines elicit better neutralizing antibodies and protection against wild-type H3N2 virus.

bioRxiv · Jul 6, 2022Microbiology

Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine

S. Gouma, M. Weirick, S. Hensley

The paper assesses the antigenic mismatch between the 2019 Southern Hemisphere influenza vaccine's H3N2 component and circulating viruses, finding a focus on antigenic site A which may reduce vaccine effectiveness.

bioRxiv · Jun 24, 2019Microbiology